ACPE Number: 0204-0000-26-716-H01-P Release Date: January 14, 2026 Expiration Date: January 14, 2029
Activity Type: Application-based CE Credit Hours: 2 contact hours Activity Fee: Member - $99 | Non-member $125
Overview
The Ambulatory Respiratory Infections Microcredential covers the prevention and treatment of streptococcal pharyngitis, influenza, COVID-19, and mpox along with antimicrobial stewardship in an outpatient setting, including testing considerations, applicable physical assessments, and treatment options. Upon completion of the microcredential, participants should be proficient in performing the diagnostic services associated with streptococcal pharyngitis, influenza, COVID-19, and mpox.
Once a learner has completed the educational curriculum, they will have the opportunity to complete an online comprehensive exam. Once the learner passes the exam (minimum 80% passing rate; unlimited attempts permitted), they will earn the Ambulatory Respiratory Infections Microcredential.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity is intended for pharmacists interested in providing point-of-care testing and diagnostic services for ambulatory respiratory infections for which they are permitted by legislation and regulation.
Wesley Kufel, PharmD, BCPS, BCIDP, FCCP, FIDSA Clinical Associate Professor State University of New York at Binghamton School of Pharmacy and Pharmaceutical Sciences Binghamton, New York Clinical Pharmacy Specialist, Infectious Diseases State University of New York Upstate University Hospital Syracuse, New York
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
Wesley Kufel: Shionogi, consultant
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Important Note – ACPE 60 Day Deadline:
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP eProfile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity.
